<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Metab Dispos</journal-id><journal-id journal-id-type="iso-abbrev">Drug Metab Dispos</journal-id><journal-id journal-id-type="pmc-domain-id">445</journal-id><journal-id journal-id-type="pmc-domain">elsevierwt</journal-id><journal-title-group><journal-title>Drug Metabolism and Disposition</journal-title></journal-title-group><issn pub-type="ppub">0090-9556</issn><issn pub-type="epub">1521-009X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Elsevier Sponsored Documents</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12164722</article-id><article-id pub-id-type="pmcid-ver">PMC12164722.1</article-id><article-id pub-id-type="pmcaid">12164722</article-id><article-id pub-id-type="pmcaiid">12164722</article-id><article-id pub-id-type="pmid">36195337</article-id><article-id pub-id-type="doi">10.1124/dmd.122.000994</article-id><article-id pub-id-type="pii">S0090-9556(24)00897-3</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Assessing Liver-to-Plasma Partition Coefficients and In Silico Calculation Methods: When Does the Hepatic Model Matter in PBPK?</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0005"><name name-style="western"><surname>Li</surname><given-names initials="X">Xiaonan</given-names></name></contrib><contrib contrib-type="author" id="au0010"><name name-style="western"><surname>Jusko</surname><given-names initials="WJ">William J.</given-names></name><email>wjjusko@buffalo.edu</email><xref rid="cor1" ref-type="corresp">*</xref></contrib><aff id="aff1">Department of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New YorkDepartment of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label><bold>Address correspondence to:</bold> William J. Jusko, Department of Pharmaceutical Sciences, State University of New York at Buffalo, 404 Pharmacy Building, Buffalo, New York 14214. E&#8211;mail: wjjusko@buffalo.edu <email>wjjusko@buffalo.edu</email></corresp></author-notes><pub-date pub-type="collection"><month>12</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>04</day><month>10</month><year>2022</year></pub-date><volume>50</volume><issue>12</issue><issue-id pub-id-type="pmc-issue-id">490594</issue-id><fpage>1501</fpage><lpage>1512</lpage><history><date date-type="received"><day>15</day><month>6</month><year>2022</year></date><date date-type="accepted"><day>9</day><month>9</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>04</day><month>10</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>14</day><month>06</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-15 14:25:23.183"><day>15</day><month>06</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2022 by The American Society for Pharmacology and Experimental Therapeutics.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>American Society for Pharmacology and Experimental Therapeutics</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="ab0005"><title>ABSTRACT:</title><sec><p>The primary models used in pharmacokinetics to assess hepatic clearance (<italic toggle="yes">CL<sub>h</sub></italic>) are the well-stirred model (WSM), the parallel tube model (PTM), and the dispersion model (DM) that differ in their internal flow patterns and assumed unbound liver concentrations. Physiologically based pharmacokinetic (PBPK) models require a hepatic intrinsic clearance (<italic toggle="yes">CL<sub>int</sub></italic>) and tissue-to-plasma partition coefficient (<italic toggle="yes">K<sub>p</sub></italic>). Given measured systemic and liver concentration-time profiles, these hepatic models perform similarly but yield model-specific <italic toggle="yes">CL<sub>int</sub></italic> and <italic toggle="yes">K<sub>p</sub></italic> estimates. This work provides mathematical relationships for the three basic hepatic models and assesses their corresponding PBPK-relevant <italic toggle="yes">K<sub>p</sub></italic> values with literature-reported single-dose blood and liver concentration-time data of 14 compounds. Model fittings were performed with an open-loop approach where the <italic toggle="yes">CL<sub>h</sub></italic> and extraction ratio (<italic toggle="yes">ER</italic>) were first estimated from fitting the blood data yielding <italic toggle="yes">CL<sub>int</sub></italic> values for the three hepatic models. The prefitted blood data served as forcing input functions to obtain PBPK-operative <italic toggle="yes">K<sub>p</sub></italic> estimates that were compared with those obtained by the tissue/plasma area ratio (AR), the Chen and Gross (C&amp;G) method, and published in silico methods. The <italic toggle="yes">CL<sub>int</sub></italic> and <italic toggle="yes">K<sub>p</sub></italic> values for the hepatic models increased with the <italic toggle="yes">ER</italic> and both showed a rank order being WSM &gt; DM &gt; PTM. Drugs with low <italic toggle="yes">ER</italic> showed no differences as expected. With model-specific <italic toggle="yes">CL<sub>int</sub></italic> and <italic toggle="yes">K<sub>p</sub></italic> values, all hepatic models predict the same steady-state <italic toggle="yes">K<sub>p</sub></italic> that is comparable to those from the AR and C&amp;G methods and reported by direct measurement. All in silico methods performed poorly for most compounds. Hepatic model selection requires cautious application and interpretation in PBPK modeling.</p></sec><sec><title>SIGNIFICANCE STATEMENT</title><p>The three hepatic models generate different single-dose (nonsteady-state) values of hepatic intrinsic clearance (<italic toggle="yes">CL<sub>int</sub></italic>) and tissue-to-plasma partition coefficient in physiologically based pharmacokinetic models especially for drugs with a high extraction ratio; however, all steady-state tissue-to-plasma partition coefficient values expected from constant rate infusion studies were the same. These findings are relevant when using these models for <italic toggle="yes">in vitro</italic>-to-<italic toggle="yes">in vivo</italic> extrapolation where a model-dependent <italic toggle="yes">CL<sub>int</sub></italic> is used to correct measured drug concentrations for depletion of the tissue by metabolism. This model dependency may also have an impact when assessing pharmacokinetic/pharmacodynamic relationships when effects relate to assumed hepatic concentrations.</p><p><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="lk0040" xlink:href="fx2.gif"/></p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><def-list><title>ABBREVIATIONS:</title><def-item><term id="key0010"><italic toggle="yes">AUC</italic></term><def><p>area under the curve</p></def></def-item><def-item><term id="key0020"><italic toggle="yes">CL<sub>b</sub></italic></term><def><p>total blood clearance</p></def></def-item><def-item><term id="key0030"><italic toggle="yes">CL<sub>h</sub></italic></term><def><p>hepatic clearance</p></def></def-item><def-item><term id="key0040"><italic toggle="yes">CL<sub>int</sub></italic></term><def><p>hepatic intrinsic clearance</p></def></def-item><def-item><term id="key0050">CQ</term><def><p>chloroquine</p></def></def-item><def-item><term id="key0060">CyA</term><def><p>cyclosporine A</p></def></def-item><def-item><term id="key0070">DLZ</term><def><p>diltiazem</p></def></def-item><def-item><term id="key0080">DM</term><def><p>dispersion model</p></def></def-item><def-item><term id="key0090">DPH</term><def><p>phenytoin</p></def></def-item><def-item><term id="key0100">DZP</term><def><p>diazepam</p></def></def-item><def-item><term id="key0110">EB</term><def><p>ethoxybenzamide</p></def></def-item><def-item><term id="key0120"><italic toggle="yes">ER</italic></term><def><p>extraction ratio</p></def></def-item><def-item><term id="key0130">FTY720</term><def><p>fingolimod</p></def></def-item><def-item><term id="key0140"><italic toggle="yes">f<sub>ub</sub></italic></term><def><p>unbound fraction in blood</p></def></def-item><def-item><term id="key0150"><italic toggle="yes">f<sub>up</sub></italic></term><def><p>unbound fraction in plasma</p></def></def-item><def-item><term id="key0160">HB</term><def><p>hexobarbital</p></def></def-item><def-item><term id="key0170">IP</term><def><p>intraperitoneal</p></def></def-item><def-item><term id="key0180">IV</term><def><p>intravenous</p></def></def-item><def-item><term id="key0190">IVIVE</term><def><p><italic toggle="yes">in vitro</italic>-to- <italic toggle="yes">in vivo</italic> extrapolation</p></def></def-item><def-item><term id="key0200"><italic toggle="yes">K<sub>p</sub></italic></term><def><p>tissue-to-plasma partition coefficient</p></def></def-item><def-item><term id="key0210">NIC</term><def><p>nicotine</p></def></def-item><def-item><term id="key0220">PBPK</term><def><p>physiologically-based pharmacokinetic</p></def></def-item><def-item><term id="key0230">PK</term><def><p>pharmacokinetic</p></def></def-item><def-item><term id="key0240">PPN</term><def><p>propranolol</p></def></def-item><def-item><term id="key0250">PTM</term><def><p>parallel tube model</p></def></def-item><def-item><term id="key0260">PTZ</term><def><p>pentazocine</p></def></def-item><def-item><term id="key0270">QD</term><def><p>quinidine</p></def></def-item><def-item><term id="key0280">QSPR</term><def><p>quantitative structure-property relationships</p></def></def-item><def-item><term id="key0290"><italic toggle="yes">R<sub>b</sub></italic></term><def><p>blood-to-plasma ratio</p></def></def-item><def-item><term id="key0300">SS</term><def><p>steady state</p></def></def-item><def-item><term id="key0310">TB</term><def><p>tolbutamide</p></def></def-item><def-item><term id="key0320">VEM</term><def><p>verapamil</p></def></def-item><def-item><term id="key0330">WSM</term><def><p>well-stirred model</p></def></def-item></def-list></front></article></pmc-articleset>